Naltrexone in the Treatment of Concurrent Alcohol Dependence and Pathological Gambling
Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
This study assessed whether naltrexone, an opioid antagonist, might be effective in reducing
excessive gambling behavior in people who also drink heavily. The efficacy of naltrexone was
evaluated in a randomized, double-blind, placebo-controlled trial. Fifty-two subjects who had
significant problems with both gambling and alcohol received 11 weeks of either naltrexone or
placebo.